Skip to main content
OpenTrials

Clinical trial condition

Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma

Explore clinical trials studying Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma trial results

Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT01145495

Conditions
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, +9 more
Locations
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
  • Palo Alto Medical Foundation Health Care Palo Alto, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

NCT01829568

Conditions
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma, +9 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details

Related conditions